Form 4: BioSig Technologies Director Steven Abelman Receives and Disposes of Shares

Director Steven Eric Abelman of BioSig Technologies, Inc. reports acquisition and disposal of common stock on July 26, 2024.

Summary

• On July 26, 2024, Steven Eric Abelman, a director at BioSig Technologies, Inc., acquired 30,000 shares of common stock.
• These shares were granted for services and were fully vested on the same date.
• The acquisition price was $0 per share, based on a closing price of $0.41 per share.
• Following the acquisition, Abelman disposed of 80,000 shares.
• After these transactions, Abelman's beneficial ownership is not specified in this filing.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports transactions. The disposal of shares could be seen as slightly negative, but without further context, it's difficult to assess the overall impact.

Positives

• The grant of shares could be seen as a positive incentive for the director.

Negatives

• The disposal of 80,000 shares by a director could be interpreted negatively by investors.

Risks

• Significant stock transactions by insiders can create uncertainty in the market.

Industry Context

This filing is a routine disclosure required by the SEC for insider transactions. It provides transparency into the trading activities of company insiders, which can be informative for investors.

Key Dates